![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 20, 2013 4:45:05 PM
"Unfortunately, the study you are interested in is not being conducted in your area. Please keep checking the website. If you find a trial you are interested in that becomes available in or near Chicago, please call the Pfizer ClinicalTrials.gov call center at 1-800-718-1021."
So, I'm thinking that maybe the enrollment must not be all that large since they are not including an area like the Chicago area. Or, the areas that will be included have enough of us "weekend warriors" to capture whatever enrollment is required.
ATRS held up quite well today given the beating the market took! Where were all the ATRS shorts the past two days??? One would think we would see more downside like most other stocks. There's resilience being demonstrated and I view that as a plus going forward!
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM